Unbiased Analysis of Today's Healthcare Issues
While at the national level, there has been much press about President Trump’s aim of compelling pharmaceutical companies to disclose prices on TV ads (since blocked in the Judiciary), at the state level changes are also afoot. A number of states are making moves to compel pharmaceutical companies to disclose drug prices. Others are compelling…
In many cases, the answer is ‘no’. At least that is the findings from a paper by Ryan and Sood (2019). As reported in FiercePharma: Sood and Ryan reviewed 166 drug pricing laws passed between 2015 and 2018 and found that 35 bills in 22 states included transparency mandates. Only seven of the laws were…
As the N.Y. Times reports, more transparency is coming to provider prices. The White House released an executive order Monday afternoon intended to require insurance companies, doctors and hospitals to give patients more information about precisely what their care will cost before they get it. More transparency is generally good and surprise billing for out-of-network costs has been a major…
As Time Magazine reports, health care prices are fucked up. Castlight is one company that is trying to shed some light on health care prices to improve transparency. Their CEO, Giovanni Colella, write the following in Forbes: To start, health insurance companies should refuse to agree to “gag clauses” with hospitals who do not want their…
Bank of America shareholders approved the purchase of Merrill Lynch on December 5, 2008. Last year in the fourth quarter, Merrill Lynch lost $15.84 billion. Bank of America President Ken Lewis knew that Merrill was at risk of huge 4th quarter losses. Ken Lewis did not tell shareholders about Merrill’s impending large losses. Why? Under oath,…